CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2019	Mar. 31, 2019
Current Assets
Cash	$ 37,940	$ 47,044
Accounts receivable, net	70,010	163,405
Inventory	115,354	78,737
Prepaids and other current assets	16,269	65,273
Total Current Assets	239,573	354,459
Property and equipment, net	412,299	452,048
Equity investments	898,292	898,292
Goodwill	1,941,149	1,941,149
Other asset	29,990	5,500
TOTAL ASSETS	3,521,303	3,651,448
Current Liabilities
Accounts payable	245,386	278,546
Note Payable	25,000	25,000
Convertible note payable, net of debt discount of $50,336 at June 30, 2019	199,603
Convertible note payable to related party net of debt discount of $5,088 at June 30, 2019	134,912
Accrued expenses	69,767	70,720
Total Current Liabilities	674,668	374,266
Commitments and Contingencies
Stockholders' Equity
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at June 30, 2019 (unaudited) and March 31, 2019, respectively
Common stock; $0.00001 par value; 200,000,000 shares authorized; 13,447,110 issued and outstanding at June 30, 2019 (unaudited) and 13,397,110 at March 31, 2019, respectively	136	135
Additional paid in capital	$ 7,019,622	$ 6,892,242
Common stock to be issued, 358,805 and 408,805 shares at June 30, 2019 (unaudited) and March 31, 2019, respectively	723,807	773,807
Accumulated deficit	$ (5,955,157)	$ (5,531,260)
Total Applied BioSciences Corp. Stockholders' Equity	1,788,408	2,134,924
Non-controlling interest	1,058,227	1,142,258
Total Stockholders' Equity	2,846,635	3,277,182
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 3,521,303	$ 3,651,448